GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.
about
Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines.Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and its kidney clearance: post-hoc analyses of four clinical trials.Gut hormone polyagonists for the treatment of type 2 diabetes.Diabetic nephropathy: Renoprotective effects of GLP1R agonists and SGLT2 inhibitors.The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin.Inhibition of Akt/mTOR/p70S6K Signaling Activity With Huangkui Capsule Alleviates the Early Glomerular Pathological Changes in Diabetic Nephropathy.Diabetic nephropathy: newer therapeutic perspectives
P2860
Q47265349-882404BB-3D9C-444B-B70E-6B796254B531Q48227892-F1FBB1CE-9D12-4127-B57D-30936FAAFAC9Q49218095-9AECDF07-A9A6-48CD-8068-4FD4C3B7A17DQ49494730-F792752F-5340-4031-AB7E-DD433ECC1F2AQ52688968-47D8002E-38D3-46E7-B663-8217CEA96DDDQ54976738-7A9B54FC-9278-4D22-8907-CDAB7ABAEBD3Q58712499-139F5D6E-D2CA-42DC-8F68-3AB272ED38F4
P2860
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.
@en
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.
@nl
type
label
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.
@en
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.
@nl
prefLabel
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.
@en
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.
@nl
P2093
P356
P1476
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.
@en
P2093
Daniël H van Raalte
Ewout J Hoorn
Jaap A Joles
Lennart Tonneijck
Mark H H Kramer
Michaël J B van Baar
P2888
P304
P356
10.1038/NRNEPH.2017.123
P407
P577
2017-09-04T00:00:00Z
P6179
1091430808